Sint Maarten: Health Care Is Reaching New Heights - World Bank Group

Washington, D. C., 29 September 2026 (PAHO) – The Pan American Health Organization/World Health Organization (PAHO/WHO) and the Government of Sint Maarten today signed the 2026–2031 Country Cooperation Strategy (CCS), establishing a six-year framework to guide cooperation to strengthen the country’s health system and improve the health and well-being of its population. The agreement was signed by PAHO Director Dr. Jarbas Barbosa and Claret M. M. Connor, Minister of Public Health, Social Development and Labor of Sint Maarten, on the sidelines of the 63rd Directing Council of PAHO in Washington, D. C. “The Country Cooperation Strategy provides a clear framework for PAHO/WHO to work with Sint Maarten to strengthen national capacities and advance the country’s health priorities,” said Dr. Barbosa.

Investigators have developed and validated a clinical decision support tool to improve the diagnosis and treatment of chronic kidney disease (CKD) at the point of care. The research will be presented at ASN Kidney Week 2026 October 22–25. Called Treat CKD, the tool draws on electronic health records data to identify CKD, classify risk by Kidney Disease: Improving Global Outcomes criteria, calculate kidney failure risk using the Kidney Failure Risk Equation, estimate cardiovascular risk using American Heart Association PREVENT equations, and provide recommendations for albuminuria testing, blood pressure management, cholesterol-lowering therapy, cardio-kidney therapies, and nephrology referral.

Future pregnancy plans don’t preclude living kidney donation, but candidates should be counseled on gestational hypertension risk. Future pregnancy plans need not rule out living kidney donation, but candidates should be counseled on hypertensive risk. New data on pregnancy after living kidney donation give transplant teams clearer numbers to share with donor candidates who may want children in the future.¹In a matched cohort study from 3 Canadian provinces, presented at American Society of Nephrology (ASN) Kidney Week 2026 by Amit X. Garg, MD, PhD, and published simultaneously in JAMA, most donor pregnancies were uncomplicated, with a modest increase in hypertensive disorders of pregnancy.¹ Will Donating a Kidney Affect Future Pregnancies? In 2024, more than 40,000 living kidney donations were reported across 88 countries.¹ For donors who may become pregnant later, Garg said the central question is whether donation will affect those pregnancies.

News|Videos|October 22, 2026 Chance, biology, and shared genetics may explain more small for gestational age births after living kidney donation. Small for gestational age births and shared donor-recipient genetics complicate the picture of pregnancy after living kidney donation. Investigators behind a new Canadian study of pregnancy after living kidney donation are weighing why donors had more small for gestational age (SGA) births than matched nondonors, and whether shared genetics with recipients could play a role.¹The matched cohort study, presented at American Society of Nephrology (ASN) Kidney Week 2026 by Amit X. Garg, MD, PhD, and published simultaneously in JAMA, spanned 3 provinces and also found a modest increase in hypertensive disorders of pregnancy among donors.¹ How Did the Study Compare Donors and Nondonors? Using linked administrative health databases from Ontario, British Columbia, and Alberta, investigators compared 385 pregnancies in 252 living kidney donors with 1,540 matched pregnancies in 1,535 nondonors.¹ To reflect donors’ healthier baseline profile, nondonors with any of 35 conditions that would preclude donation were excluded.